Breaking News
Investing Pro 0
👀 Bezos, Buffett & Berkowitz: What's in Their Portfolios? Unlock Data

Viking Therapeutics sell-off is unwarranted, attractive opportunity to add - Truist

Published Mar 21, 2023 15:28
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters.
 
ALT
-2.85%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
VKTX
+1.96%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

By Vlad Schepkov

Shares of Viking Therapeutics (NASDAQ:VKTX) are trading down over 15% late into Tuesday's session, in a move linked to the disappointing clinical data posted by VKTX's competitor Altimmune, Inc. (NASDAQ:ALT).

Altimmune's weight loss drug candidate pemvidutide failed to show a drop in fasting glucose or HbA1c at week 12, despite demonstrating a strong weight loss - invigorating fears VKTX's own weight loss candidate, VK2735, may run into similar issues.

Analysts at Truist Securities took to the defense of Viking Therapeutics in the face of the sell-off, noting they see "minimal read-through from pemvidutide's topline data to VK2735."

They expanded that "VK2735, unlike pemvidutide (GLP1/glucagon dual agonist), does not directly activate glucagon. Therefore, there are minimal concerns around adversely impacting the glycemic parameter in patients." The analysts added that "GIP agonism is reported to attenuate the nauseating effects of GLP-1 agonism," and they believe "VK2735 will likely have better tolerability profile compared to pemviduti

They concluded that today's major sell-off in VKTX "is unwarranted and an attractive opportunity to add," as Truist reiterates the shares at "Buy" with a $28 price target.

Shares of VKTX are trading over 15% lower late on Tuesday. ALT is down over 54%.

Viking Therapeutics sell-off is unwarranted, attractive opportunity to add - Truist
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email